Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Integra Lifesciences Holdings (IART) Income from Continuing Operations (2016 - 2026)

Integra Lifesciences Holdings' Income from Continuing Operations history spans 17 years, with the latest figure at 1704000.0 for Q4 2025.

  • On a quarterly basis, Income from Continuing Operations fell 108.77% to 1704000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 516474000.0, a 7338.77% decrease, with the full-year FY2025 number at 516474000.0, down 7337.7% from a year prior.
  • Income from Continuing Operations hit 1704000.0 in Q4 2025 for Integra Lifesciences Holdings, up from 5404000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for IART hit a ceiling of 52946000.0 in Q4 2022 and a floor of 484073000.0 in Q2 2025.
  • Historically, Income from Continuing Operations has averaged 5302550.0 across 5 years, with a median of 19665500.0 in 2023.
  • Biggest five-year swings in Income from Continuing Operations: surged 9603.52% in 2021 and later tumbled 3803.18% in 2025.
  • Tracing IART's Income from Continuing Operations over 5 years: stood at 45384000.0 in 2021, then rose by 16.66% to 52946000.0 in 2022, then crashed by 62.54% to 19834000.0 in 2023, then fell by 2.01% to 19435000.0 in 2024, then plummeted by 108.77% to 1704000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for IART at 1704000.0 in Q4 2025, 5404000.0 in Q3 2025, and 484073000.0 in Q2 2025.